ArticleBJUI compass2026
Predictors of adherence to surveillance cystoscopy for patients with non-muscle invasive bladder cancer.
Article in BJUI compass, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictors of adherence to surveillance cystoscopy for patients with non-muscle invasive bladder cancer.BJUI compass · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify factors associated with decreased adherence to the national risk-stratified surveillance cystoscopy schedule for non-muscle invasive bladder cancer (NMIBC). Patients and methods: A retrospective, IRB-approved review was conducted at a single academic institution to identify patients diagnosed with NMIBC who underwent cystoscopy. Patient demographics were collected and driving distance to the urology clinic was calculated. Area Deprivation Index (ADI) and Distressed Communities Index (DCI) were used as proxies for socio-economic status (SES). Clinical data included year of diagnosis, cancer stage, risk stratification per national guidelines, pathology results and surveillance cystoscopy dates. The primary outcome was 12-month adherence to surveillance cystoscopy. Stepwise model selection using logistic regression identified factors associated with adherence. Results: Of 591 patients identified, 351 had a confirmed pathological diagnosis and complete follow-up data. After excluding 57 patients who experienced recurrence, 112/294 (38.1%) were found to be compliant with the one-year surveillance schedule. Adherence was inversely associated with travel time to the clinic (OR 0.99, 95% CI 0.99-1.00; Conclusions: Travel time emerged as a significant barrier to adherence to NMIBC surveillance guidelines, whereas patients' SES did not appear to influence compliance. These findings suggest that logistical obstacles may play a more prominent role than socio-economic factors. Incorporating telehealth solutions and local partnerships may improve adherence and outcomes for NMIBC patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.